Increased fasting total and active GLP-1 as well as circulating total GLP-1 concentrations have been measured in obese (T2DM) patients on metformin treatment [54–56], Different mechanisms have been proposed to explain this increase [57]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.